000 | 01410 a2200361 4500 | ||
---|---|---|---|
005 | 20250518021503.0 | ||
264 | 0 | _c20190528 | |
008 | 201905s 0 0 eng d | ||
022 | _a1532-2777 | ||
024 | 7 |
_a10.1016/j.mehy.2019.01.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaad, Rahoma E | |
245 | 0 | 0 |
_aCollagenous colitis development occurs after long standing mucosal healing in IBD with TNF-α inhibitors, and could be due to exaggerated healing response from excess TNF-α inhibition. _h[electronic resource] |
260 |
_bMedical hypotheses _cFeb 2019 |
||
300 |
_a90-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aColitis, Collagenous _xmetabolism |
650 | 0 | 4 |
_aColitis, Ulcerative _xgenetics |
650 | 0 | 4 |
_aCrohn Disease _xgenetics |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xgenetics |
650 | 0 | 4 |
_aIntestinal Mucosa _xmetabolism |
650 | 0 | 4 |
_aMucous Membrane _xpathology |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
650 | 0 | 4 | _aWound Healing |
700 | 1 | _aShobar, Rima | |
700 | 1 | _aMutlu, Ece A | |
773 | 0 |
_tMedical hypotheses _gvol. 123 _gp. 90-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mehy.2019.01.004 _zAvailable from publisher's website |
999 |
_c29306564 _d29306564 |